Literature DB >> 21945319

Respiratory chain complex I, a main regulatory target of the cAMP/PKA pathway is defective in different human diseases.

Sergio Papa1, Domenico De Rasmo, Zuzana Technikova-Dobrova, Damiano Panelli, Anna Signorile, Salvatore Scacco, Vittoria Petruzzella, Francesco Papa, Giuseppe Palmisano, Antonio Gnoni, Loris Micelli, Anna Maria Sardanelli.   

Abstract

In mammals, complex I (NADH-ubiquinone oxidoreductase) of the mitochondrial respiratory chain has 31 supernumerary subunits in addition to the 14 conserved from prokaryotes to humans. Multiplicity of structural protein components, as well as of biogenesis factors, makes complex I a sensible pace-maker of mitochondrial respiration. The work reviewed here shows that the cAMP/PKA pathway regulates the biogenesis, assembly and catalytic activity of complex I and mitochondrial oxygen superoxide production. The structural, functional and regulatory complexity of complex I, renders it particularly vulnerable to genetic and sporadic pathological factors. Complex I dysfunction has, indeed, been found, to be associated with several human diseases. Knowledge of the pathogenetic mechanisms of these diseases can help to develop new therapeutic strategies. Copyright Â
© 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945319     DOI: 10.1016/j.febslet.2011.09.019

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  26 in total

Review 1.  Role of AMP-activated protein kinase in metabolic depression in animals.

Authors:  Mark H Rider
Journal:  J Comp Physiol B       Date:  2015-07-15       Impact factor: 2.200

Review 2.  Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies.

Authors:  Fatima Djouadi; Jean Bastin
Journal:  Cells       Date:  2019-03-28       Impact factor: 6.600

Review 3.  Cardiac mitochondrial matrix and respiratory complex protein phosphorylation.

Authors:  Raul Covian; Robert S Balaban
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-10       Impact factor: 4.733

Review 4.  The mitochondrial complex I of trypanosomatids--an overview of current knowledge.

Authors:  Margarida Duarte; Ana M Tomás
Journal:  J Bioenerg Biomembr       Date:  2014-06-25       Impact factor: 2.945

Review 5.  Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.

Authors:  Oded Bergman; Dorit Ben-Shachar
Journal:  Can J Psychiatry       Date:  2016-08       Impact factor: 4.356

Review 6.  The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson's disease and in schizophrenia.

Authors:  Dorit Ben-Shachar
Journal:  J Neural Transm (Vienna)       Date:  2019-12-17       Impact factor: 3.575

7.  Changes in the phosphoproteome of brown adipose tissue during hibernation in the ground squirrel, Ictidomys tridecemlineatus.

Authors:  Gaëtan Herinckx; Nusrat Hussain; Fred R Opperdoes; Kenneth B Storey; Mark H Rider; Didier Vertommen
Journal:  Physiol Genomics       Date:  2017-07-10       Impact factor: 3.107

Review 8.  OXPHOS mutations and neurodegeneration.

Authors:  Werner J H Koopman; Felix Distelmaier; Jan A M Smeitink; Peter H G M Willems
Journal:  EMBO J       Date:  2012-11-13       Impact factor: 11.598

Review 9.  Complex-I-ty in aging.

Authors:  Jae H Hur; Devon A Stork; David W Walker
Journal:  J Bioenerg Biomembr       Date:  2014-06-25       Impact factor: 2.945

Review 10.  An update on complex I assembly: the assembly of players.

Authors:  Rasika S Vartak; Manpreet Kaur Semwal; Yidong Bai
Journal:  J Bioenerg Biomembr       Date:  2014-07-17       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.